Australia's Neuren Pharma hits over 3-month high on $32 mln share buyback

Neuren Pharmaceuticals

13/11/2024 23:47

** Shares of Neuren Pharmaceuticals  NEU.AX  rise as much as
8.4% to A$17.940, their highest since Aug. 5
    ** Stock biggest pct gainer on the benchmark S&P/ASX 200
index  .AXJO  
    ** Drug manufacturer announces commencement of on-market
share buyback programme of up to A$50 mln ($32.47 mln)
    ** Says will buy up to 3 mln shares at A$16.540 per share,
based on the last close of Wednesday
    ** Stock down 33.8% YTD

($1 = 1.5401 Australian dollars)

 (Reporting by Kumar Tanishk in Bengaluru)
 ((Tanishk.Kumar@thomsonreuters.com;))